---
figid: PMC3159114__fig-10
figlink: /pmc/articles/PMC3159114/figure/f10/
number: F10
caption: Role of GPx-1 in modulating apoptosis. The extrinsic pathway of apoptosis
  involves activation of caspase pathways that promote cell death. ROS activates both
  survival and apoptotic pathways. GPx-1 by modulating cellular hydrogen peroxide
  can inhibit both pro-survival and pro-apoptotic pathways. The end result (cell death
  or survival) may depend on the extent and levels of ROS generated. Interestingly,
  excess ROS as found in GPx-1 deficiency may alter nuclear factor κB (NFκB) signaling
  to promote pro-apoptotic responses. Normally, NFκB activation results in the upregulation
  of IAPs and other antiapoptotic genes. Similarly, extracellular signal-related kinase
  (ERK) and Akt activation can promote IAP or FLICE-inhibitory protein (FLIP) expression
  to inhibit caspase cascades. c-Jun-amino terminal (stress-activated) kinase (JNK)
  activation, which can be attenuated by NFκB, augments apoptotic pathways by further
  stimulating ROS production. GPx-1 overexpression has been shown to specifically
  suppress the activation of Akt and NFκB pathways. GPx-1 specifically blocks NFκB
  activation by preventing the degradation of the NFκB inhibitor inhibitor of κB.
  The intrinsic pathway of apoptosis involves the release of apoptogens like apoptosis-inducing
  factor (AIF) or cytochrome c from mitochondria. These pathways may be activated
  by ROS (including hydrogen and lipid hydroperoxides) and caspase cascades that promote
  Bid (Bcl-2 interacting domain) cleavage. GPx-1 has been shown to attenuate AIF release
  and enhance the expression of Bcl-2, an antiapoptotic factor.
pmcid: PMC3159114
papertitle: 'Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms
  to Therapeutic Opportunities.'
reftext: Edith Lubos, et al. Antioxid Redox Signal. 2011 Oct 1;15(7):1957-1997.
pmc_ranked_result_index: '86879'
pathway_score: 0.9086538
filename: fig-10.jpg
figtitle: Role of GPx-1 in modulating apoptosis
year: '2011'
organisms:
- Homo sapiens
ndex: 7e94f2ba-df11-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3159114__fig-10.html
  '@type': Dataset
  description: Role of GPx-1 in modulating apoptosis. The extrinsic pathway of apoptosis
    involves activation of caspase pathways that promote cell death. ROS activates
    both survival and apoptotic pathways. GPx-1 by modulating cellular hydrogen peroxide
    can inhibit both pro-survival and pro-apoptotic pathways. The end result (cell
    death or survival) may depend on the extent and levels of ROS generated. Interestingly,
    excess ROS as found in GPx-1 deficiency may alter nuclear factor κB (NFκB) signaling
    to promote pro-apoptotic responses. Normally, NFκB activation results in the upregulation
    of IAPs and other antiapoptotic genes. Similarly, extracellular signal-related
    kinase (ERK) and Akt activation can promote IAP or FLICE-inhibitory protein (FLIP)
    expression to inhibit caspase cascades. c-Jun-amino terminal (stress-activated)
    kinase (JNK) activation, which can be attenuated by NFκB, augments apoptotic pathways
    by further stimulating ROS production. GPx-1 overexpression has been shown to
    specifically suppress the activation of Akt and NFκB pathways. GPx-1 specifically
    blocks NFκB activation by preventing the degradation of the NFκB inhibitor inhibitor
    of κB. The intrinsic pathway of apoptosis involves the release of apoptogens like
    apoptosis-inducing factor (AIF) or cytochrome c from mitochondria. These pathways
    may be activated by ROS (including hydrogen and lipid hydroperoxides) and caspase
    cascades that promote Bid (Bcl-2 interacting domain) cleavage. GPx-1 has been
    shown to attenuate AIF release and enhance the expression of Bcl-2, an antiapoptotic
    factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP3
  - AIFM1
  - AKT3
  - NFKB1
  - MAPK8
  - CFLAR
  - GPX1
  - MAPK10
  - CASP8
  - AKT1
  - CASP12
  - TNF
  - CASP14
  - CASP1
  - FAS
  - MAPK1
  - NFKB2
  - BID
  - MAPK9
  - CASP4
  - CASP5
  - AKT2
  - BAX
  - REL
  - RELA
  - RELB
  - CASP6
  - MAPK3
  - BAK1
  - CASP2
  - CASP10
  - BCL2
  - CASP9
  - CASP7
  - Cancer
genes:
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: AIF
  symbol: AIF
  source: hgnc_alias_symbol
  hgnc_symbol: AIFM1
  entrez: '9131'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: FLIP,
  symbol: FLIP
  source: hgnc_alias_symbol
  hgnc_symbol: CFLAR
  entrez: '8837'
- word: GPx-1)
  symbol: GPX1
  source: hgnc_symbol
  hgnc_symbol: GPX1
  entrez: '2876'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: (TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Fas
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: Bid
  symbol: BID
  source: hgnc_symbol
  hgnc_symbol: BID
  entrez: '637'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Bax/Bak
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Bax/Bak
  symbol: BAK
  source: hgnc_alias_symbol
  hgnc_symbol: BAK1
  entrez: '578'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3159114__F10
redirect_from: /figures/PMC3159114__F10
figtype: Figure
---
